Cargando…

Clinical outcomes associated with guideline-discordant management of asymptomatic bacteriuria and urinary tract infection in hospitalized patients with neurogenic bladder

OBJECTIVE: To compare clinical outcomes associated with appropriate and inappropriate management of asymptomatic bacteriuria (ASB) and urinary tract infection (UTI) among inpatients with neurogenic bladder (NB). DESIGN: Multicenter, retrospective cohort. SETTING: The study was conducted across 4 Vet...

Descripción completa

Detalles Bibliográficos
Autores principales: Fitzpatrick, Margaret A., Wirth, Marissa, Nguyen, Jimmy, Suda, Katie J., Weaver, Frances M., Burns, Stephen, Collins, Eileen, Safdar, Nasia, Patel, Ursula, Evans, Charlesnika T.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cambridge University Press 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9879921/
https://www.ncbi.nlm.nih.gov/pubmed/36712473
http://dx.doi.org/10.1017/ash.2022.348
_version_ 1784878796568002560
author Fitzpatrick, Margaret A.
Wirth, Marissa
Nguyen, Jimmy
Suda, Katie J.
Weaver, Frances M.
Burns, Stephen
Collins, Eileen
Safdar, Nasia
Patel, Ursula
Evans, Charlesnika T.
author_facet Fitzpatrick, Margaret A.
Wirth, Marissa
Nguyen, Jimmy
Suda, Katie J.
Weaver, Frances M.
Burns, Stephen
Collins, Eileen
Safdar, Nasia
Patel, Ursula
Evans, Charlesnika T.
author_sort Fitzpatrick, Margaret A.
collection PubMed
description OBJECTIVE: To compare clinical outcomes associated with appropriate and inappropriate management of asymptomatic bacteriuria (ASB) and urinary tract infection (UTI) among inpatients with neurogenic bladder (NB). DESIGN: Multicenter, retrospective cohort. SETTING: The study was conducted across 4 Veterans’ Affairs hospitals. PARTICIPANTS: The study included veterans with NB due to spinal cord injury or disorder (SCI/D), multiple sclerosis (MS), or Parkinson’s disease (PD) hospitalized between January 1, 2017, and December 31, 2018, with diagnosis of ASB or UTI. INTERVENTIONS: In a medical record review, we classified ASB and UTI diagnoses and treatments as appropriate or inappropriate based on national guidelines. MAIN OUTCOME MEASURES: Frequencies of Clostridioides difficile infection, acute kidney injury, 90-day hospital readmission, postculture length-of-stay (LOS), and multidrug-resistant organisms in subsequent urine cultures were compared between those who received appropriate and inappropriate management. RESULTS: We included 170 encounters with ASB (30%) or UTI (70%) diagnoses occurring for 166 patients. Overall, 86.1% patients were male, 47.6% had SCI/D and 77.6% used bladder catheters. All ASB encounters had appropriate diagnoses, and 96.1% had appropriate treatment. In contrast, 37 UTI encounters (31.1%) had inappropriate diagnoses and 61 (51.3%) had inappropriate treatment, including 30 encounters with true ASB. Among patients with SCI/D or MS, appropriate ASB or UTI diagnosis was associated with a longer postculture LOS (median, 14 vs 7.5 days; P = .02). We did not detect any significant associations between appropriate versus inappropriate diagnosis and treatment and other outcomes. CONCLUSIONS: Almost one-third of UTI diagnoses and half of treatments in hospitalized patients with NB are inappropriate. Opportunities exist to improve ASB and UTI management in patients with NB to minimize inappropriate antibiotic use.
format Online
Article
Text
id pubmed-9879921
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Cambridge University Press
record_format MEDLINE/PubMed
spelling pubmed-98799212023-01-28 Clinical outcomes associated with guideline-discordant management of asymptomatic bacteriuria and urinary tract infection in hospitalized patients with neurogenic bladder Fitzpatrick, Margaret A. Wirth, Marissa Nguyen, Jimmy Suda, Katie J. Weaver, Frances M. Burns, Stephen Collins, Eileen Safdar, Nasia Patel, Ursula Evans, Charlesnika T. Antimicrob Steward Healthc Epidemiol Original Article OBJECTIVE: To compare clinical outcomes associated with appropriate and inappropriate management of asymptomatic bacteriuria (ASB) and urinary tract infection (UTI) among inpatients with neurogenic bladder (NB). DESIGN: Multicenter, retrospective cohort. SETTING: The study was conducted across 4 Veterans’ Affairs hospitals. PARTICIPANTS: The study included veterans with NB due to spinal cord injury or disorder (SCI/D), multiple sclerosis (MS), or Parkinson’s disease (PD) hospitalized between January 1, 2017, and December 31, 2018, with diagnosis of ASB or UTI. INTERVENTIONS: In a medical record review, we classified ASB and UTI diagnoses and treatments as appropriate or inappropriate based on national guidelines. MAIN OUTCOME MEASURES: Frequencies of Clostridioides difficile infection, acute kidney injury, 90-day hospital readmission, postculture length-of-stay (LOS), and multidrug-resistant organisms in subsequent urine cultures were compared between those who received appropriate and inappropriate management. RESULTS: We included 170 encounters with ASB (30%) or UTI (70%) diagnoses occurring for 166 patients. Overall, 86.1% patients were male, 47.6% had SCI/D and 77.6% used bladder catheters. All ASB encounters had appropriate diagnoses, and 96.1% had appropriate treatment. In contrast, 37 UTI encounters (31.1%) had inappropriate diagnoses and 61 (51.3%) had inappropriate treatment, including 30 encounters with true ASB. Among patients with SCI/D or MS, appropriate ASB or UTI diagnosis was associated with a longer postculture LOS (median, 14 vs 7.5 days; P = .02). We did not detect any significant associations between appropriate versus inappropriate diagnosis and treatment and other outcomes. CONCLUSIONS: Almost one-third of UTI diagnoses and half of treatments in hospitalized patients with NB are inappropriate. Opportunities exist to improve ASB and UTI management in patients with NB to minimize inappropriate antibiotic use. Cambridge University Press 2022-12-09 /pmc/articles/PMC9879921/ /pubmed/36712473 http://dx.doi.org/10.1017/ash.2022.348 Text en © The Author(s) 2022 This is a work of the US Government and is not subject to copyright protection within the United States. Published by Cambridge University Press on behalf of The Society for Healthcare Epidemiology of America. https://creativecommons.org/licenses/by/4.0/This is an Open Access article, distributed under the terms of the Creative Commons Attribution licence (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted re-use, distribution and reproduction, provided the original article is properly cited.
spellingShingle Original Article
Fitzpatrick, Margaret A.
Wirth, Marissa
Nguyen, Jimmy
Suda, Katie J.
Weaver, Frances M.
Burns, Stephen
Collins, Eileen
Safdar, Nasia
Patel, Ursula
Evans, Charlesnika T.
Clinical outcomes associated with guideline-discordant management of asymptomatic bacteriuria and urinary tract infection in hospitalized patients with neurogenic bladder
title Clinical outcomes associated with guideline-discordant management of asymptomatic bacteriuria and urinary tract infection in hospitalized patients with neurogenic bladder
title_full Clinical outcomes associated with guideline-discordant management of asymptomatic bacteriuria and urinary tract infection in hospitalized patients with neurogenic bladder
title_fullStr Clinical outcomes associated with guideline-discordant management of asymptomatic bacteriuria and urinary tract infection in hospitalized patients with neurogenic bladder
title_full_unstemmed Clinical outcomes associated with guideline-discordant management of asymptomatic bacteriuria and urinary tract infection in hospitalized patients with neurogenic bladder
title_short Clinical outcomes associated with guideline-discordant management of asymptomatic bacteriuria and urinary tract infection in hospitalized patients with neurogenic bladder
title_sort clinical outcomes associated with guideline-discordant management of asymptomatic bacteriuria and urinary tract infection in hospitalized patients with neurogenic bladder
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9879921/
https://www.ncbi.nlm.nih.gov/pubmed/36712473
http://dx.doi.org/10.1017/ash.2022.348
work_keys_str_mv AT fitzpatrickmargareta clinicaloutcomesassociatedwithguidelinediscordantmanagementofasymptomaticbacteriuriaandurinarytractinfectioninhospitalizedpatientswithneurogenicbladder
AT wirthmarissa clinicaloutcomesassociatedwithguidelinediscordantmanagementofasymptomaticbacteriuriaandurinarytractinfectioninhospitalizedpatientswithneurogenicbladder
AT nguyenjimmy clinicaloutcomesassociatedwithguidelinediscordantmanagementofasymptomaticbacteriuriaandurinarytractinfectioninhospitalizedpatientswithneurogenicbladder
AT sudakatiej clinicaloutcomesassociatedwithguidelinediscordantmanagementofasymptomaticbacteriuriaandurinarytractinfectioninhospitalizedpatientswithneurogenicbladder
AT weaverfrancesm clinicaloutcomesassociatedwithguidelinediscordantmanagementofasymptomaticbacteriuriaandurinarytractinfectioninhospitalizedpatientswithneurogenicbladder
AT burnsstephen clinicaloutcomesassociatedwithguidelinediscordantmanagementofasymptomaticbacteriuriaandurinarytractinfectioninhospitalizedpatientswithneurogenicbladder
AT collinseileen clinicaloutcomesassociatedwithguidelinediscordantmanagementofasymptomaticbacteriuriaandurinarytractinfectioninhospitalizedpatientswithneurogenicbladder
AT safdarnasia clinicaloutcomesassociatedwithguidelinediscordantmanagementofasymptomaticbacteriuriaandurinarytractinfectioninhospitalizedpatientswithneurogenicbladder
AT patelursula clinicaloutcomesassociatedwithguidelinediscordantmanagementofasymptomaticbacteriuriaandurinarytractinfectioninhospitalizedpatientswithneurogenicbladder
AT evanscharlesnikat clinicaloutcomesassociatedwithguidelinediscordantmanagementofasymptomaticbacteriuriaandurinarytractinfectioninhospitalizedpatientswithneurogenicbladder